RDUS (radiuspharm.com) Bozor qiymatining balans qiymatiga nisbati

Radius Recycling Inc. (RDUS) kompaniyasining rasmiy ramzlari

Radius Recycling, Inc. (RDUS) uchun xavflar metallom qoldiqlarining narxlari tebranishi va avtomobil sanoatidagi pasayish bilan bog'liq. GURU.Markets platformasidagi bozor kapitalizatsiyasining balans hisoboti dinamikasi yon tomonga yo'nalgan tendentsiyani ko'rsatmoqda, bunda 1.61 oxirgi metrika darajasini aks ettiradi. Biznes daromadlari sanoat ishlab chiqarishi va po'lat kotirovkalariga bog'liq, shu bilan birga kompaniya yuqori operatsion ishonchlilikni va hamkorlari tomonidan B2B ishonchini saqlab qolmoqda.

RDUS Radius Pharmaceuticals: Balans qiymatiga nisbatan bozor qiymati 04.07.2022 - 26.07.2025 oraligʻida
Radius Health original mahsuloti

Ushbu koeffitsiyent kompaniyaning sof aktivlariga nisbatan bozor premiumini belgilaydi. Narxning bukhgalteriya qiymatiga nisbati koeffitsiyenti tahlili bukhgalteriya qiymati va bozor baholovi orasidagi farqni baholash imkonini beradi. Ushbu ko'rsatkichning oshishi investorlarning ortiqcha kutganliklari yoki nomoddiy aktivlarning yuqori qiymati haqida signal beradi. Radius Recycling, Inc. (RDUS) uchun bu innovatsion osteoporoz dori vositalarini ishlab chiqishdagi intellektual salohiyatning kapitalizatsiyasini aks ettiradi. Premium yangi terapiya shakllarining tijorat muvaffaqiyatiga bozor ishonchini tasdiqlaydi.

Asosiy raqobatchilar

Ascendis Pharma A/S - Bozor qiymatining balans qiymatiga nisbati|MDGL (madrigalpharma.com) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Corcept Therapeutics Incorporated CORT|Sof aktivlarga nisbatan bozor kapitallashuvi Rhythm Pharma|Akero Therapeutics Inc (AKRO) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Metsera Therapeutics (MTSR)|Bozor kapitallashuvining balans qiymatiga nisbati MLTX (MoonLake Immunotherapeutics)|crinetics.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati NewAmsterdam Pharma Company N.V. (NAMS)|SLNO: Balans qiymatiga nisbatan bozor qiymati|FOLD (Amicus Pharma) - Bozor qiymatining balans qiymatiga nisbati|89bio Pharma (ETNB) - Kapitallashuvning sof aktivlarga nisbati|AGIO (Agios Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati structuretx.com (GPCR)|MiMedx (MDXG) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati RZLT (Rezolute Inc)|Lexicon Pharma - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati MBX Corp MBX|ALT (Altimmune, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|aardvarktherapeutics.com (AARD) - Bozor qiymatining balans qiymatiga koeffitsiyenti|SGMT - Kapitallashuvning sof aktivlarga nisbati|BioAge Labs (BIOA) - Bozor kapitallashuvining balans qiymatiga multiplikatori|BMEA (Biomea) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Quince|Bozor kapitallashuvining balans qiymatiga nisbati Fractyl Health, Inc. (GUTS)|Bozor qiymatining balans qiymatiga nisbati VTVT (vtvtherapeutics.com)|ATPC: Bozor qiymatining balans qiymatiga nisbati|Pluristem Therapeutics - Bozor qiymatining balans qiymatiga koeffitsiyenti|SYBX - Bozor qiymatining balans qiymatiga nisbati|LPCN - Bozor qiymatining balans qiymatiga nisbati|matinasbiopharma.com - Bozor kapitallashuvining balans qiymatiga nisbati|SPRB (sprucebiosciences.com) - Balans qiymatiga nisbatan bozor kapitallashuvi|GLTO: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi CTCX|Bozor qiymatining balans qiymatiga nisbati LUMO (Lumos Pharma Corp)|Kapitallashuvning sof aktivlarga nisbati ONVO (Organovo Corp)